Clinical Scorecard: Subtypes of Non-thyroidal Illness Syndrome and Their Relationship with Mortality in Sepsis: The Role of Thyroid Autoantibodies
At a Glance
Category
Detail
Condition
Non-thyroidal illness syndrome (NTIS) in sepsis
Key Mechanisms
Disruption of hypothalamic–pituitary–thyroid axis with altered thyroid hormone metabolism and presence of thyroid autoantibodies
Target Population
Patients with sepsis admitted to tertiary hospital ICU
Care Setting
Tertiary hospital intensive care unit
Key Highlights
NTIS is highly prevalent (82%) among septic patients and independently predicts increased in-hospital mortality.
NTIS subtypes NTIS-1 (isolated low T3) and NTIS-2 (combined low T3 and T4) are associated with approximately fourfold higher mortality risk.
Thyroglobulin antibody (TGAb) positivity doubles mortality risk and is a strong independent prognostic factor in sepsis.
Guideline-Based Recommendations
Diagnosis
Perform thyroid function tests (FT3, FT4, TSH) within 24 hours of sepsis diagnosis to identify NTIS and its subtypes.
Measure thyroid autoantibodies, especially thyroglobulin antibody (TGAb), to enhance risk stratification.
Management
Recognize NTIS, particularly NTIS-1 and NTIS-2 subtypes, as markers of high mortality risk in septic patients.
Consider integrating thyroid function and antibody status into clinical decision-making for prognosis.
Monitoring & Follow-up
Monitor thyroid hormone levels and antibody status during sepsis to assess disease progression and risk.
Use Sequential Organ Failure Assessment (SOFA) score alongside thyroid parameters for comprehensive evaluation.
Risks
NTIS and positive TGAb status are associated with increased risk of in-hospital mortality in sepsis.
TPOAb positivity may trend toward increased mortality but lacks definitive statistical significance.
Patient & Prescribing Data
Septic patients with and without NTIS admitted to tertiary hospital ICU
No direct treatment interventions for NTIS or thyroid antibodies were evaluated; however, identification of high-risk NTIS subtypes and TGAb positivity may inform prognosis and guide supportive care intensity.
Clinical Best Practices
Early assessment of thyroid function and autoantibodies in septic patients to identify NTIS subtypes and antibody positivity.
Incorporate NTIS subtype classification and TGAb status into mortality risk stratification models.
Adjust clinical monitoring and supportive care based on combined thyroid hormone and antibody profiles alongside established severity scores.
